NEW: Find Out Why We're Different
Recently Registered: Yale University | Lexicon Pharmaceuticals | Protagonist Therapeutics | Flagship Pioneering
Novo Nordisk posts strong 2026 start and Wegovy pill surge: Wegovy pill surpasses 2 million prescriptions since January launch
Obesity has officially overtaken oncology as largest contributor to biopharma pipeline value for first time in deloitte’s industry analysis, underscoring commercial momentum behind next-generation weight-loss therapies
Eli Lilly doubles down on its obesity franchise with a $4.5 billion expansion across its Indian manufacturing network

Michael Gibson

Michael Gibson

President & Chief Executive Officer Baim Institute for Clinical Research

Seminars

Wednesday 15th July 2026

Session Reserved for Baim Institute of Clinical Research

5:10 pm

michael gibson

View all Speakers

View Event Brochure